Frankfurt-am-Main, Germany

Hauke Szillat

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2004-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Hauke Szillat: Innovator in Pharmaceutical Chemistry

Introduction

Hauke Szillat is a prominent inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of five patents. His work focuses on developing innovative compounds that target specific biological pathways, particularly in the treatment of various diseases.

Latest Patents

Among his latest patents is the invention of isoxazolidines as RIPK1 inhibitors. This patent relates to the use of isoxazolidines in treating diseases and disorders mediated by receptor-interacting protein kinase 1. Another notable patent involves isothiazolopyridine-2-carboxamides, which are designed as pharmaceuticals. These compounds are inhibitors of transglutaminases, particularly transglutaminase 2 (TGM2), and are suitable for treating degenerative joint diseases such as osteoarthritis. The patent also includes processes for preparing these compounds and their pharmaceutical compositions.

Career Highlights

Hauke Szillat has worked with notable companies in the pharmaceutical industry, including Sanofi-Aventis Deutschland GmbH and Genzyme Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Throughout his career, Szillat has collaborated with esteemed colleagues such as Hans Matter and Martin Lorenz. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.

Conclusion

Hauke Szillat is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of various diseases. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…